Atorvastatin Calcium
Product Images NDC 68258-6993

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68258-6993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-6992-09 (Ndc 68258 6992 09 Ohm)

Atorvastatin Calcium 10 mg film-coated tablets, bottle label for 90 tablets. The label includes the NDC 68258-6992-09 and product number 6A0590. It states the active ingredient as Atorvastatin Calcium USP equivalent to 10 mg Atorvastatin. Label also shows storage instructions, manufacturer OHM Laboratories, and is packaged exclusively by Dispensing Solutions, Inc.*

FDA Label Image

Ndc 68258-6993-09 (Ndc 68258 6993 09 Ohm)

Atorvastatin Calcium 20 mg film-coated tablets label by Dispensing Solutions, Inc. The label indicates a package size of 90 tablets with NDC 68258-6993-09 and product number 6A0690. It includes storage instructions to keep out of children's reach and store at 68°-77°F. The label also provides manufacturer information (OHM Laboratories Inc.), dosage instructions, and warnings to report muscle problems to a physician.*

FDA Label Image

Figure1 (Figatorva1)

A line graph showing cumulative incidence percentage over time in years, comparing Atorvastatin and Placebo groups. The graph plots increased incidence for both groups up to 3.5 years, with Atorvastatin consistently lower than Placebo. Statistical data including hazard ratio (HR=0.64) and p-value (0.0005) are noted, indicating significance.*

FDA Label Image

Figure2 (Figatorva2)

A line chart comparing cumulative hazard percentages over time for Atorvastatin Calcium versus placebo. The x-axis represents years to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentages. Atorvastatin shows a consistently lower hazard than placebo throughout the period.*

FDA Label Image

Figure3 (Figatorva3)

A line graph showing the proportion of subjects experiencing a major cardiovascular event over five years, comparing two dosages of Atorvastatin: 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with a confidence interval and a p-value of 0.0002, indicating statistical analysis of the data.*

FDA Label Image

Structure (Structureatorva)

Chemical structure of Atorvastatin Calcium, showing the molecular components, including aromatic rings, hydroxyl groups, fluorine atom, calcium ions (Ca2+), and three water molecules (3H2O), consistent with the active ingredient atorvastatin calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.